Sign in

CIK 0002023658

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Bicara Therapeutics Inc.

Sign in to watch
Ticker
BCAX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-468-4219
Business address
116 HUNTINGTON AVENUE SUITE 703, BOSTON, MA, 02116
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$400,716
in 1 filing, $401K under 10b5-1 plans

Net −$400,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Cohlhepp Ryan −$401K President, COO & Interim CEO sold 9% of stake
Date Insider Transaction Shares Price Value Owned after
2026-04-15 Cohlhepp Ryan President and COO Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −8,000 109,334
2026-03-16 Cohlhepp Ryan President and COO Exercise or conversion 10b5-1 +8,000 $3.79 $30K 213,141
2026-03-16 Cohlhepp Ryan President and COO Sale 10b5-1 −8,000 $19.66 $157K 205,141
2026-03-16 Cohlhepp Ryan President and COO Sale 10b5-1 −4,500 $19.66 $88K 200,641
2026-03-16 Cohlhepp Ryan President and COO Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −8,000 117,334
2026-03-03 Cohlhepp Ryan President and COO Exercise or conversion 10b5-1 +12,892 $3.79 $49K 222,533
2026-03-03 Cohlhepp Ryan President and COO Sale 10b5-1 −12,892 $18.16 $234K 209,641
2026-03-03 Cohlhepp Ryan President and COO Sale 10b5-1 −4,500 $18.16 $82K 205,141
2026-03-03 Cohlhepp Ryan President and COO Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −12,892 125,334
2026-02-25 Cohlhepp Ryan President and COO Exercise or conversion 10b5-1 +3,108 $3.79 $12K 213,272
2026-02-25 Cohlhepp Ryan President and COO Sale 10b5-1 −3,108 $18.04 $56K 210,164
2026-02-25 Cohlhepp Ryan President and COO Sale 10b5-1 −523 $18.04 $9K 209,641
2026-02-25 Cohlhepp Ryan President and COO Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −3,108 138,226
2026-02-02 Cohlhepp Ryan President and COO Grant or award · Stock Option (Right to Buy) +300,000 300,000
2026-01-22 Cohlhepp Ryan President and COO Sale 10b5-1 −3,828 $18.10 $69K 210,164
2026-01-15 Cohlhepp Ryan President and COO Sale 10b5-1 −149 $18.02 $3K 213,992
2025-12-26 Cohlhepp Ryan President and COO Exercise or conversion +25,000 $4.44 $111K 214,141
2025-12-26 Cohlhepp Ryan President and COO Exercise or conversion · Stock Option (Right to Buy) −25,000 39,909
2025-12-15 Cohlhepp Ryan President and COO Exercise or conversion 10b5-1 +8,000 $3.79 $30K 201,641
2025-12-15 Cohlhepp Ryan President and COO Sale 10b5-1 −8,000 $18.68 $149K 193,641

Page 2 of 3 · 58 trades